Literature DB >> 24076310

Ontogenic changes in lung cholesterol metabolism, lipid content, and histology in mice with Niemann-Pick type C disease.

Charina M Ramirez1, Adam M Lopez, Lam Q Le, Kenneth S Posey, Arthur G Weinberg, Stephen D Turley.   

Abstract

Niemann-Pick Type C (NPC) disease is caused by a deficiency of either NPC1 or NPC2. Loss of function of either protein results in the progressive accumulation of unesterified cholesterol in every tissue leading to cell death and organ damage. Most literature on NPC disease focuses on neurological and liver manifestations. Pulmonary dysfunction is less well described. The present studies investigated how Npc1 deficiency impacts the absolute weight, lipid composition and histology of the lungs of Npc1(-/-) mice (Npc1(nih)) at different stages of the disease, and also quantitated changes in the rates of cholesterol and fatty acid synthesis in the lung over this same time span (8 to 70days of age). Similar measurements were made in Npc2(-/-) mice at 70days. All mice were of the BALB/c strain and were fed a basal rodent chow diet. Well before weaning, the lung weight, cholesterol and phospholipid (PL) content, and cholesterol synthesis rate were all elevated in the Npc1(-/-) mice and remained so at 70days of age. In contrast, lung triacylglycerol content was reduced while there was no change in lung fatty acid synthesis. Despite the elevated PL content, the composition of PL in the lungs of the Npc1(-/-) mice was unchanged. H&E staining revealed an age-related increase in the presence of lipid-laden macrophages in the alveoli of the lungs of the Npc1(-/-) mice starting as early as 28days. Similar metabolic and histologic changes were evident in the lungs of the Npc2(-/-) mice. Together these findings demonstrate an intrinsic lung pathology in NPC disease that is of early onset and worsens over time.
© 2013.

Entities:  

Keywords:  2-hydroxypropyl-ß-cyclodextrin; 2HPßCD; ALT; AST; Alveoli; E/L; Liver; Niemann–Pick C1; Niemann–Pick C2; Npc1; Npc2; PC; PE; PG; PI; PS; Phospholipid; Pulmonary; SM; TAG; Triacylglycerol; UC; alanine aminotransferase; aspartate aminotransferase; body weight; bw; endosomal/lysosomal; phosphatidylcholine; phosphatidylethanolamine; phosphatidylglycerol; phosphatidylinositol; phosphatidylserine; sphingomyelin; triacylglycerol; unesterified cholesterol

Mesh:

Substances:

Year:  2013        PMID: 24076310      PMCID: PMC3849124          DOI: 10.1016/j.bbalip.2013.09.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  51 in total

1.  Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease.

Authors:  Benny Liu
Journal:  Clin Lipidol       Date:  2012-06

2.  Niemann-Pick C1 modulates hepatic triglyceride metabolism and its genetic variation contributes to serum triglyceride levels.

Authors:  Riikka-Liisa Uronen; Per Lundmark; Marju Orho-Melander; Matti Jauhiainen; Kristina Larsson; Agneta Siegbahn; Lars Wallentin; Björn Zethelius; Olle Melander; Ann-Christine Syvänen; Elina Ikonen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-20       Impact factor: 8.311

Review 3.  Defective cholesterol trafficking in Niemann-Pick C-deficient cells.

Authors:  Kyle B Peake; Jean E Vance
Journal:  FEBS Lett       Date:  2010-04-21       Impact factor: 4.124

4.  Deletion of Scap in alveolar type II cells influences lung lipid homeostasis and identifies a compensatory role for pulmonary lipofibroblasts.

Authors:  Valérie Besnard; Susan E Wert; Mildred T Stahlman; Anthony D Postle; Yan Xu; Machiko Ikegami; Jeffrey A Whitsett
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

5.  Receptor-mediated and bulk-phase endocytosis cause macrophage and cholesterol accumulation in Niemann-Pick C disease.

Authors:  Benny Liu; Chonglun Xie; James A Richardson; Stephen D Turley; John M Dietschy
Journal:  J Lipid Res       Date:  2007-05-02       Impact factor: 5.922

6.  Type C Niemann-Pick disease in a boxer dog.

Authors:  M Kuwamura; T Awakura; A Shimada; T Umemura; K Kagota; N Kawamura; M Naiki
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Clinical, electrophysiological, and serum biochemical measures of progressive neurological and hepatic dysfunction in feline Niemann-Pick type C disease.

Authors:  Charles H Vite; Wenge Ding; Caroline Bryan; Patricia O'Donnell; Karyn Cullen; David Aleman; Mark E Haskins; Thomas Van Winkle
Journal:  Pediatr Res       Date:  2008-11       Impact factor: 3.756

8.  Rapid separation of neutral lipids, free fatty acids and polar lipids using prepacked silica Sep-Pak columns.

Authors:  J G Hamilton; K Comai
Journal:  Lipids       Date:  1988-12       Impact factor: 1.880

9.  Protein replacement therapy partially corrects the cholesterol-storage phenotype in a mouse model of Niemann-Pick type C2 disease.

Authors:  Gitte Krogh Nielsen; Frederik Dagnaes-Hansen; Ida Elisabeth Holm; Steve Meaney; Derek Symula; Niels Trolle Andersen; Christian Würtz Heegaard
Journal:  PLoS One       Date:  2011-11-03       Impact factor: 3.240

10.  Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression.

Authors:  Cristin D Davidson; Nafeeza F Ali; Matthew C Micsenyi; Gloria Stephney; Sophie Renault; Kostantin Dobrenis; Daniel S Ory; Marie T Vanier; Steven U Walkley
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

View more
  10 in total

1.  Roles of the Mevalonate Pathway and Cholesterol Trafficking in Pulmonary Host Defense.

Authors:  Kristin A Gabor; Michael B Fessler
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

2.  Pulmonary involvement in Niemann-Pick C type 1.

Authors:  Orna Staretz-Chacham; M Aviram; I Morag; A Goldbart; E Hershkovitz
Journal:  Eur J Pediatr       Date:  2018-07-31       Impact factor: 3.183

3.  Systemic administration of 2-hydroxypropyl-β-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function.

Authors:  Adam M Lopez; Sandi J Terpack; Kenneth S Posey; Benny Liu; Charina M Ramirez; Stephen D Turley
Journal:  Clin Exp Pharmacol Physiol       Date:  2014-10       Impact factor: 2.557

4.  Niemann-Pick C1-deficient mice lacking sterol O-acyltransferase 2 have less hepatic cholesterol entrapment and improved liver function.

Authors:  Adam M Lopez; Ryan D Jones; Joyce J Repa; Stephen D Turley
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-07       Impact factor: 4.052

5.  Ontogenesis and Modulation of Intestinal Unesterified Cholesterol Sequestration in a Mouse Model of Niemann-Pick C1 Disease.

Authors:  Adam M Lopez; Charina M Ramirez; Anna M Taylor; Ryan D Jones; Joyce J Repa; Stephen D Turley
Journal:  Dig Dis Sci       Date:  2019-07-17       Impact factor: 3.199

6.  Impact of the loss of caveolin-1 on lung mass and cholesterol metabolism in mice with and without the lysosomal cholesterol transporter, Niemann-Pick type C1.

Authors:  Dorothy I Mundy; Adam M Lopez; Kenneth S Posey; Jen-Chieh Chuang; Charina M Ramirez; Philipp E Scherer; Stephen D Turley
Journal:  Biochim Biophys Acta       Date:  2014-04-18

7.  Extensive macrophage accumulation in young and old Niemann-Pick C1 model mice involves the alternative, M2, activation pathway and inhibition of macrophage apoptosis.

Authors:  Gail Deutsch; Akshay Muralidhar; Ellen Le; Ivan A Borbon; Robert P Erickson
Journal:  Gene       Date:  2015-12-18       Impact factor: 3.688

Review 8.  Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin.

Authors:  Jean E Vance; Barbara Karten
Journal:  J Lipid Res       Date:  2014-03-24       Impact factor: 5.922

9.  Correlation of age of onset and clinical severity in Niemann-Pick disease type C1 with lysosomal abnormalities and gene expression.

Authors:  Laura L Baxter; Dawn E Watkins-Chow; Nicholas L Johnson; Nicole Y Farhat; Frances M Platt; Ryan K Dale; Forbes D Porter; William J Pavan; Jorge L Rodriguez-Gil
Journal:  Sci Rep       Date:  2022-02-09       Impact factor: 4.996

10.  Gender-Specific Effects of Two Treatment Strategies in a Mouse Model of Niemann-Pick Disease Type C1.

Authors:  Carsten Holzmann; Martin Witt; Arndt Rolfs; Veronica Antipova; Andreas Wree
Journal:  Int J Mol Sci       Date:  2021-03-03       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.